Cambridge Investment Research Advisors Inc. Trims Position in Celsius Holdings, Inc. (NASDAQ:CELH)

Cambridge Investment Research Advisors Inc. cut its holdings in shares of Celsius Holdings, Inc. (NASDAQ:CELH) by 0.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 56,787 shares of the company’s stock after selling 353 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Celsius were worth $4,709,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of CELH. Cary Street Partners Investment Advisory LLC increased its holdings in shares of Celsius by 1,350.0% during the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company’s stock valued at $25,000 after purchasing an additional 135 shares in the last quarter. Contravisory Investment Management Inc. purchased a new position in shares of Celsius during the 4th quarter valued at approximately $25,000. Transcendent Capital Group LLC purchased a new position in shares of Celsius during the 4th quarter valued at approximately $25,000. Tidemark LLC purchased a new position in shares of Celsius during the 4th quarter valued at approximately $29,000. Finally, Heritage Wealth Advisors increased its holdings in shares of Celsius by 200.0% during the 4th quarter. Heritage Wealth Advisors now owns 552 shares of the company’s stock valued at $30,000 after purchasing an additional 368 shares in the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CELH shares. Morgan Stanley reaffirmed an “equal weight” rating and set a $75.00 target price on shares of Celsius in a report on Tuesday. Jefferies Financial Group lifted their price target on shares of Celsius from $98.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, March 18th. Roth Mkm lifted their price target on shares of Celsius from $90.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, March 14th. Piper Sandler lifted their price target on shares of Celsius from $76.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, March 1st. Finally, Wedbush reissued an “outperform” rating and issued a $100.00 price target on shares of Celsius in a research note on Friday, May 3rd. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $89.82.

Insider Activity

In other news, major shareholder Dean Desantis sold 100,000 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total transaction of $9,575,000.00. Following the transaction, the insider now owns 219,257 shares of the company’s stock, valued at approximately $20,993,857.75. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, insider Paul H. Storey sold 1,833 shares of the business’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $75.43, for a total value of $138,263.19. Following the sale, the insider now directly owns 41,044 shares in the company, valued at approximately $3,095,948.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Dean Desantis sold 100,000 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total transaction of $9,575,000.00. Following the completion of the sale, the insider now owns 219,257 shares in the company, valued at $20,993,857.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,896,696 shares of company stock valued at $119,390,609. 2.20% of the stock is currently owned by insiders.

Celsius Trading Down 0.5 %

CELH traded down $0.35 on Tuesday, hitting $65.82. 8,919,964 shares of the company’s stock were exchanged, compared to its average volume of 4,840,273. Celsius Holdings, Inc. has a fifty-two week low of $45.03 and a fifty-two week high of $99.62. The firm has a 50-day moving average price of $79.59 and a 200-day moving average price of $69.51. The stock has a market cap of $15.34 billion, a price-to-earnings ratio of 72.33, a P/E/G ratio of 2.03 and a beta of 1.93.

Celsius (NASDAQ:CELH) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.07. The firm had revenue of $355.70 million for the quarter, compared to analysts’ expectations of $390.37 million. Celsius had a net margin of 18.63% and a return on equity of 111.29%. The company’s revenue was up 36.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.13 EPS. On average, equities analysts predict that Celsius Holdings, Inc. will post 1.11 EPS for the current year.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.